Current Pharmaceutical Design, Volume 17 - Number 5

Editorial [Hot Topic: Novel Therapeutic Strategies in Neural Diseases Uncover Unexpected Disease Connections: From Neurodegeneration and Addiction to Pain and Depression (Guest Editor: Gonzalo Herradon)]

, 17(5): 408 - 409

Gonzalo Herradon

DOI: 10.2174/138161211795164121

Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System

, 17(5): 410 - 423

Takashi Muramatsu

DOI: 10.2174/138161211795164167

Gene Therapy as a Novel Pharmaceutical Intervention for Stroke

, 17(5): 424 - 433

Hiroaki Ooboshi

DOI: 10.2174/138161211795164149

Uncovering New Pharmacological Targets to Treat Neuropathic Pain by Understanding How the Organism Reacts to Nerve Injury

, 17(5): 434 - 448

Yasmina B. Martin, Gonzalo Herradon and Laura Ezquerra

DOI: 10.2174/138161211795164130

Connecting Parkinsons Disease and Drug Addiction: Common Players Reveal Unexpected Disease Connections and Novel Therapeutic Approaches

, 17(5): 449 - 461

Esther Gramage and Gonzalo Herradon

DOI: 10.2174/138161211795164103

Identification of New Drug Targets and Biomarkers Related to Obesity and Eating Disorders: an Approach Based on Reward Deficit and Addiction

, 17(5): 462 - 470

Luis F Alguacil, Elisabet Salas and Carmen Gonzalez-Martin

DOI: 10.2174/138161211795164158

Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment

, 17(5): 471 - 488

Elaine Del-Bel, Fernando Eduardo Padovan-Neto, Rita Raisman-Vozari and Marcio Lazzarini

DOI: 10.2174/138161211795164176

The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease

, 17(5): 489 - 507

Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina and Rita Raisman-Vozari

DOI: 10.2174/138161211795164095

Immunotherapy for Alzheimers Disease: Rational Basis in Ongoing Clinical Trials

, 17(5): 508 - 520

Manuel Menendez-Gonzalez, Pablo Perez-Pinera, Marta Martinez-Rivera, Alfonso Lopez Muniz and Jose A. Vega

DOI: 10.2174/138161211795164112

New Strategies in the Development of Antidepressants: Towards the Modulation of Neuroplasticity Pathways

, 17(5): 521 - 533

Rebeca Vidal, Fuencisla Pilar-Cuellar, Severiano dos Anjos, Raquel Linge, Begona Treceno, Veronica Ines Vargas, Antonio Rodriguez-Gaztelumendi, Ricardo Mostany, Elena Castro, Alvaro Diaz, Elsa M. Valdizan and Angel Pazos

DOI: 10.2174/138161211795164086

Webmaster Contact:
Copyright © 2018 Bentham Science